Quick Answer
TEVA PHARMACEUTICAL INDUSTRIES LTD reported Gross Profit of $8.94 billion for fiscal year 2025.
TEVA PHARMACEUTICAL INDUSTRIES LTD Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $8.94B | +10.8% |
| 2024 | $8.06B | +5.5% |
| 2023 | $7.64B | +9.6% |
| 2022 | $6.97B | -8.2% |
| 2021 | $7.59B | -1.7% |
| 2020 | $7.73B | +2.5% |
| 2019 | $7.54B | -9.1% |
| 2018 | $8.30B | -21.8% |
| 2017 | $10.62B | -8.9% |
| 2016 | $11.65B | +2.6% |
| 2015 | $11.36B | +2.7% |
| 2014 | $11.06B | +3.3% |
| 2013 | $10.71B | +0.5% |
| 2012 | $10.65B | +11.9% |
| 2011 | $9.52B | +5.0% |
| 2010 | $9.06B | +23.0% |
| 2009 | $7.37B | +23.4% |
| 2008 | $5.97B | +22.4% |
| 2007 | $4.88B | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.30B | +7.3% | +9.6% |
| June 30, 2025 | $2.10B | +3.9% | +12.0% |
| March 31, 2025 | $1.88B | +6.0% | -12.6% |
| September 30, 2024 | $2.15B | +16.0% | +6.1% |
| June 30, 2024 | $2.02B | +12.7% | +14.3% |
| March 31, 2024 | $1.77B | +11.9% | -4.3% |
| September 30, 2023 | $1.85B | +10.9% | +3.1% |
| June 30, 2023 | $1.80B | +0.1% | +13.5% |
- TEVA PHARMACEUTICAL INDUSTRIES LTD showed an increase of +10.8% in Gross Profit compared to the prior fiscal year.
- Over the 2007–2025 period, TEVA PHARMACEUTICAL INDUSTRIES LTD’s gross profit has grown by 83.3% (from $4.88 billion to $8.94 billion).
- The most recent figure is from TEVA PHARMACEUTICAL INDUSTRIES LTD’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: